Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats
2011
Kannen, Vinicius | Marini, Tassiana | Turatti, Aline | Carvalho, Milene C. | Brandão, Marcus L. | Jabor, Valquiria A.P. | Bonato, Pierina S. | Ferreira, Frederico R. | Zanette, Dalila L. | Silva, Wilson A. Jr | Garcia, Sérgio B.
Fluoxetine (FLX) is a drug commonly used as antidepressant. However, its effects on tumorigenesis remain controversial. Aiming to evaluate the effects of FLX treatment on early malignant changes, we analyzed serotonin (5-HT) metabolism and recognition, aberrant crypt foci (ACF), proliferative process, microvessels, vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) expression in colon tissue. Male Wistar rats received a daily FLX-gavage (30mgkg⁻¹) and, a single dose of 1,2 dimethylhydrazine (DMH; i.p., 125mgkg⁻¹). After 6 weeks of FLX-treatment, our results revealed that FLX and nor-fluoxetine (N-FLX) are present in colon tissue, which was related to significant increase in serotonin (5-HT) levels (P<0.05) possibly through a blockade in SERT mRNA (serotonin reuptake transporter; P<0.05) resulting in lower 5-hydroxyindoleacetic acid (5-HIAA) levels (P<0.01) and, 5-HT2C receptor mRNA expressions. FLX-treatment decreased dysplastic ACF development (P<0.01) and proliferative process (P<0.001) in epithelia. We observed a significant decrease in the development of malignant microvessels (P<0.05), VEGF (P<0.001), and COX-2 expression (P<0.01). These findings suggest that FLX may have oncostatic effects on carcinogenic colon tissue, probably due to its modulatory activity on 5-HT metabolism and/or its ability to reduce colonic malignant events.
显示更多 [+] 显示较少 [-]